Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × Maintenance × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Recurrence 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Trastuzumab 494 Paclitaxel 465 Cyclophosphamide 461 Docetaxel 408 Capecitabine 340 Letrozole 290 Fulvestrant 255 Doxorubicin 239 Carboplatin 223 Tamoxifen 212 Anastrozole 177 Radiotherapy 173 exemestane 171 Epirubicin 170 Bevacizumab 161 Lapatinib 141 Vinorelbine 139 Gemcitabine 137 pembrolizumab 135 pertuzumab 134 palbociclib 120 Exercise 108 Fluorouracil 101 Magnetic Resonance Spectroscopy 99 Albumin-Bound Paclitaxel 99 eribulin 94 130-nm albumin-bound paclitaxel 87 Everolimus 84 Cisplatin 79 Taxes 76

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05051631 2025-08-28

BRAVE

Vanderbilt University Medical Center

Phase NA Completed

1,071 enrolled 11 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡